BillionToOne, Inc.
- BLLN
- NASDAQ
- Medical - Diagnostics & Research
- Molecular Diagnostics
- DNA Quantification/Sequencing
$101.03
Today +2.97%Quote Oct 19, 2026, 08:00 PM UTC
−4.62%over the last month
Max drawdown −25.5%From 1-month high −19.1%3 months −23.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About BillionToOne
BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Employees
713
Market value
$4.77B
Quote Oct 19
Floor
$100.21
0.8% below price
Resistance
$102.39
1.3% above price
Price vs analyst targets
4 analysts
Lowest target
$120.00Highest target
$130.00
$120.00Highest target
$130.00
- Price $101.03
- Average target $126.00
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 25% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about BLLNPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free